132 related articles for article (PubMed ID: 667850)
1. Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
Allen LM
Cancer Res; 1978 Aug; 38(8):2549-54. PubMed ID: 667850
[No Abstract] [Full Text] [Related]
2. The role of drug disposition kinetics on cellular transport of the antineoplastic agent VM-26.
Allen L
Drug Metab Rev; 1978; 8(1):119-35. PubMed ID: 720213
[No Abstract] [Full Text] [Related]
3. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB
Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of etoposide and its analogs].
Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.
Pamidi CC; Derry WB; Gupta RS
Anticancer Drug Des; 1991 Nov; 6(5):481-93. PubMed ID: 1764166
[TBL] [Abstract][Full Text] [Related]
7. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Kerrigan D; Pommier Y; Kohn KW
NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
[TBL] [Abstract][Full Text] [Related]
8. Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells.
Lee T; Roberts D
Cancer Res; 1984 Jul; 44(7):2986-90. PubMed ID: 6722822
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by 4'-demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) of human lymphoblast cultures in G2 phase of the cell cycle.
Misra NC; Roberts DW
Cancer Res; 1975 Jan; 35(1):99-105. PubMed ID: 1053697
[TBL] [Abstract][Full Text] [Related]
10. A quantitative microdensitometric and autoradiographic study of the effect of 4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26) on the cell cycle of cultured fibroblasts.
Gotzos V; Cappelli-Gotzos B; Despond JM
Histochem J; 1979 Nov; 11(6):691-707. PubMed ID: 536243
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
[TBL] [Abstract][Full Text] [Related]
12. VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Mechl Z; Rovný F; Sopková B
Neoplasma; 1977; 24(4):411-4. PubMed ID: 904743
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
[TBL] [Abstract][Full Text] [Related]
14. [The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
Jankowski RP; Vahrson H
Med Klin; 1977 Dec; 72(49):2122-6. PubMed ID: 337083
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
White JC; Hines LH; Rathmell JP
Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845
[TBL] [Abstract][Full Text] [Related]
16. Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
Roberts D; Hilliard S; Peck C
Cancer Res; 1980 Nov; 40(11):4225-31. PubMed ID: 7471063
[No Abstract] [Full Text] [Related]
17. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
Roberts D; Peck C; Hilliard S; Karas JG
Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998
[No Abstract] [Full Text] [Related]
18. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
Gupta RS; Singh B
J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
[TBL] [Abstract][Full Text] [Related]
19. Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.
Holthuis JJ
Pharm Weekbl Sci; 1988 Jun; 10(3):101-16. PubMed ID: 3047665
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.
Daley L; Guminski Y; Demerseman P; Kruczynski A; Etiévant C; Imbert T; Hill BT; Monneret C
J Med Chem; 1998 Nov; 41(23):4475-85. PubMed ID: 9804687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
